Items where authors include "Braun, A."
Article
Uluer, A.Z., MacGregor, G., Azevedo, P. et al. (103 more authors) (2023) Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials. The Lancet Respiratory Medicine, 11 (6). pp. 550-562. ISSN 2213-2600
von Moos, R., Body, J.J., Egerdie, B. et al. (12 more authors) (2016) Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. Supportive Care in Cancer, 24 (3). pp. 1327-1337. ISSN 0941-4355
Stopeck, A.T., Fizazi, K., Body, J.J. et al. (16 more authors) (2016) Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer. Supportive Care in Cancer, 24 (1). pp. 447-455. ISSN 0941-4355
Lipton, A., Fizazi, K., Stopeck, A.T. et al. (12 more authors) (2016) Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics. EUROPEAN JOURNAL OF CANCER, 53. pp. 75-83. ISSN 0959-8049
Smith, M.R., Coleman, R.E. orcid.org/0000-0002-4275-1043, Klotz, L. et al. (9 more authors) (2015) Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events. Annals of Oncology, 26 (2). pp. 368-374. ISSN 0923-7534
Matza, L.S., Chung, K., Van Brunt, K. et al. (6 more authors) (2014) Health state utilities for skeletal-related events secondary to bone metastases. European Journal of Health Economics, 15 (1). pp. 7-18. ISSN 1618-7598
Matza, L.S., Cong, Z., Chung, K. et al. (6 more authors) (2013) Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases. Patient Preference and Adherence, 7. pp. 855-865. ISSN 1177-889X